Skip to main content

11 Result(s)

within F. M. Rosenthal Remove this filter

and

  1. No Access

    Chapter

    Procédures thérapeutiques particulières

    Les cellules souches hématopoïétiques sont une petite population essentiellement dormante de cellules indifférenciées. Elles sont caractérisées par leur capacité d’auto-renouvellement par division cellulaire c...

    B. Deschler, C. I. Müller, C. F. Waller… in Précis d’hématologie et d’oncologie (2011)

  2. Chapter

    Particular Treatment Procedures

    Barbara Deschler, Cornelius Waller… in Concise Manual of Hematology and Oncology (2008)

    Download PDF (811 KB)

  3. No Access

    Article

    Gentherapie in der Onkologie

    Ch. v. Kalle, H. Veelken, F. M. Rosenthal in Der Onkologe (1999)

  4. No Access

    Article

    NTS influence on transgene expression from mono- and bicistronic plasmid vectors after lipofection in a human fibroblast cell line

     We evaluated the survival, transgene production, and copy numbers of integrated plasmid units per host genome after lipofection with mono- and bicistronic plasmid vectors in different cell lines and under var...

    P. Kulmburg, H. Veelken, C. Schmoor, F. M. Rosenthal… in Journal of Molecular Medicine (1997)

  5. No Access

    Chapter and Conference Paper

    Potent Presentation of Soluble Protein Antigens by In Vitro-Generated Dendritic Cells from Peripheral Blood CD34+ Progenitor Cells

    Dendritic cells (DC) are potent antigen-presenting cells (APC) and thus are specifically involved in the initiation of antigen-specific immune responses. Due to their potent costimulatory activity, they are we...

    B. Herbst, P. Fisch, A. Mackensen, G. Köhler… in Symposium in Immunology VI (1997)

  6. No Access

    Chapter and Conference Paper

    Somatic Gene Therapy in Cancer

    Cancer is rapidly becoming the leading medical cause of death in Western society. Currently, the most important treatment modalities in clinical oncology are surgery, radiotherapy, and chemotherapy with cytost...

    F. M. Rosenthal, C. F. Waller, A. Lindemann, R. Mertelsmann in Cellular Therapy (1997)

  7. No Access

    Chapter and Conference Paper

    Tumor Immunotherapy by IL-2 and IL-2 Gene Transfected Cells

    Tumortherapy is based on a variety of treatment modalities. Directly operating cytoreductive approaches are designed to work either locally like surgery or radiotherapy, or systemically like cytotoxic drugs. O...

    A. Lindemann, F. M. Rosenthal, A. Mackensen, H. Veelken, P. Kulmburg… in Acute Leukemias V (1996)

  8. No Access

    Article

    Pilot study for the evaluation of T-cell-mediated tumor immunotherapy by cytokine gene transfer in patients with malignant tumors

    R. Mertelsmann, A. Lindemann, T. Boehm, U. Brennscheidt… in Journal of Molecular Medicine (1995)

  9. No Access

    Article

    Guidelines for the design and implementation of clinical studies in somatic cell therapy and gene therapy

    A. Lindemann, F. M. Rosenthal, R. Mertelsmann, S. Hase… in Journal of Molecular Medicine (1995)

  10. No Access

    Chapter and Conference Paper

    Cytokines and Hematopoietins: Physiology, Pathophysiology, and Potential as Therapeutic Agents

    Improved understanding of host biology, immunology, and tumor pathophysiology raises the possibility of introducing new treatment modalities for cancer patients: stimulation of host defense mechanisms, includi...

    R. Mertelsmann, F. M. Rosenthal, A. Lindemann… in Supportive Care in Cancer Patients II (1991)

  11. No Access

    Chapter and Conference Paper

    Interleukins and Haematopoietic Growth Factors

    One of the most challenging areas of contemporary oncological and immunological research is represented by investigation of the potential clinical use of human cytokines.

    F. M. Rosenthal, A. Lindemann, F. Herrmann… in Lymphohaematopoietic Growth Factors in Can… (1990)